July 17-22, 2022
Glasgow, Scotland, UK
Mast cell silencing: a novel therapeutic approach for urticarial and other mast cell-mediated diseases
Summary Chronic urticaria (CU) is a mast cell (MC)-dependent disease with limited therapeutic options. Current management strategies are directed at inhibiting IgE-mediated activation of MCs and